Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Z61
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,438
Award facts
- Contract value 100% obligated
- $12,438.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,438.15 to AmerisourceBergen Drug Corp for 30 tablets of TAGRISSO 80 mg, with an ultimate completion date of February 11, 2026. This is a firm fixed-price, non-set-aside contract executed on January 21, 2026, with performance at the awardee's Conshohocken, Pennsylvania facility. TAGRISSO (osimertinib) is an oncology medication used to treat specific types of lung cancer, reflecting the pharmaceutical distributor's role in supplying specialized medical commodities to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. This comprehensive IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor, continues to demonstrate its capability to fulfill federal procurement requirements for essential medical commodities across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DR26F9Z61?
SPE2DR26F9Z61 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9Z61 worth?
The government has obligated $12,438 on SPE2DR26F9Z61.
Is contract SPE2DR26F9Z61 an order under another contract?
Yes. SPE2DR26F9Z61 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Z61 competed?
The extent of competition for SPE2DR26F9Z61 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award